| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03.11. | Onward Medical N.V. reports Q3 results | 19 | Seeking Alpha | ||
| 03.11. | ONWARD Medical NV: ONWARD Medical Delivers Revenue of EUR 2.5M in Q3 2026, with Sustained Commercial Momentum and Strong Clinical Execution | 684 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, Nov. 03, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function... ► Artikel lesen | |
| 27.10. | ONWARD Medical NV: ONWARD Medical to Announce Third-Quarter 2026 Results on November 3, 2026 | 569 | GlobeNewswire (Europe) | EINDHOVEN, The Netherlands, Oct. 27, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function... ► Artikel lesen | |
| 21.10. | ONWARD Medical NV: ONWARD Medical Announces the Appointment of Fouad Azzam to its Board of Directors | 570 | GlobeNewswire (Europe) | Fouad Azzam is a Partner with EQT Life Sciences, bringing extensive experience investing in and supporting fast-growing medical technology and life sciences companiesEINDHOVEN, the Netherlands, Oct.... ► Artikel lesen | |
| ONWARD MEDICAL NV ADR Aktie jetzt für 0€ handeln | |||||
| 09.09. | Onward Medical N.V. reports 1H results | 12 | Seeking Alpha | ||
| 09.09. | ONWARD Medical NV: ONWARD Medical Reports First Half 2026 Results with Strong Product Revenue Growth and Continued Progress across ARC Therapy Pipeline | 1.641 | GlobeNewswire (Europe) | THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
EINDHOVEN, the Netherlands, Sept. 09, 2026 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
| 04.09. | ONWARD Medical NV: ONWARD Medical to Announce First-Half 2026 Results on September 9, 2026 | 787 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, Sept. 04, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function... ► Artikel lesen | |
| 03.09. | ONWARD Medical NV: ONWARD Medical Announces First Implant in New Clinical Feasibility Study Evaluating ARC-IM System to Restore Mobility After Spinal Cord Injury | 715 | GlobeNewswire (Europe) | The EIGER study will assess the safety and preliminary effectiveness of the investigational
ARC-IM System
to restore mobility after both subacute and chronic spinal cord injuryARC-IM is... ► Artikel lesen | |
| 26.05. | ONWARD Medical NV: ONWARD Medical Reports First Quarter 2026 Results with Strong Commercial Momentum and Key Clinical Milestones | 1.550 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, May 26, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function... ► Artikel lesen | |
| 19.05. | ONWARD Medical NV: ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | 837 | GlobeNewswire (Europe) | EINDHOVEN, The Netherlands, May 19, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function... ► Artikel lesen | |
| 13.05. | ONWARD Medical NV: ONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders | 1.123 | GlobeNewswire (Europe) | THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
Shareholders approve all proposed resolutions
EINDHOVEN,... ► Artikel lesen | |
| 20.04. | ONWARD Medical NV: ONWARD Medical Publishes Closing of Bookbuild Offering | 1.286 | GlobeNewswire (Europe) | THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
EINDHOVEN, the Netherlands, April 20, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| 17.04. | ONWARD Medical schliesst Kapitalerhöhung über 40 Mio. Euro erfolgreich ab | 1.203 | Moneycab | Eindoven / Lausanne - ONWARD Medical N.V. (Euronext: ONWD - US-ADR: ONWRY), das Neurotechnologie-Unternehmen, das wegweisende Therapien zur Wiederherstellung von Bewegung, Funktion und Unabhängigkeit... ► Artikel lesen | |
| 17.04. | ONWARD Medical schliesst Kapitalerhöhung über 40 Millionen Euro erfolgreich ab | 1.066 | Moneycab | Eindoven / Lausanne - ONWARD Medical N.V. (Euronext: ONWD - US-ADR: ONWRY), das Neurotechnologie-Unternehmen, das wegweisende Therapien zur Wiederherstellung von Bewegung, Funktion und Unabhängigkeit... ► Artikel lesen | |
| 16.04. | ONWARD Medical NV: ONWARD Medical Successfully Raises over EUR 40 Million in Capital Increase | 944 | GlobeNewswire (Europe) | NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER... ► Artikel lesen | |
| 15.04. | ONWARD Medical NV: ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 40 Million | 964 | GlobeNewswire (Europe) | NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER... ► Artikel lesen | |
| 01.04. | ONWARD Medical NV: ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions | 883 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, April 01, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function... ► Artikel lesen | |
| 31.03. | ONWARD Medical NV: ONWARD Medical Reports Full Year 2025 Financial and Operating Results, Highlighting Strong US Commercial Performance and Major Pipeline Milestones | 1.621 | GlobeNewswire (Europe) | THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
EINDHOVEN, the Netherlands, March 31, 2026 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
| 23.03. | ONWARD Medical NV: ONWARD Medical Schedules Webcast to Report Full-Year 2025 Financial Results and Provide Business Update | 904 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, March 23, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function... ► Artikel lesen | |
| 04.02. | ONWARD Medical NV: ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury | 1.255 | GlobeNewswire (Europe) | Empower BP is a landmark global pivotal study evaluating the safety and effectiveness
of the implantable ARC-IM System
to address blood pressure instability after spinal cord injury (SCI)Blood... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 51,55 | -0,44 % | Fresenius gewinnt eine neue Wachstumsstory | Fresenius hat den schwierigen Teil seiner Neuaufstellung offenbar weitgehend hinter sich gelassen. Der Gesundheitskonzern steigert seine Profitabilität, reduziert die finanzielle Belastung und hebt... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,760 | +2,83 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,230 | -1,35 % | Siemens Healthineers Aktie: Zwischen Übergangsjahr und Kursfantasie | Die Analysten sind sich nach den jüngsten Quartalszahlen von Siemens Healthineers uneinig über die weiteren Perspektiven der Aktie. Während Jefferies nach der Erholung im Geschäft mit medizinischer... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,56 | -0,67 % | BMO raises BrightSpring Health stock price target on LDD momentum | ||
| HEARTFLOW | 45,730 | +2,42 % | Heartflow stock tumbles despite strong growth beating Q3 expectations | ||
| LIFESTANCE HEALTH GROUP | 13,630 | +2,17 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 25,300 | +2,47 % | Privia Health Group, Inc.: Privia Health Reports Strong Results in the 2025 Performance Year of the Medicare Shared Savings Program | ||
| GERRESHEIMER | 32,060 | -2,85 % | Gerresheimer: Was Anleger vor dem Jahresfinale prüfen sollten | ||
| PROGYNY | 35,860 | +1,16 % | Rekorde bei Familienplanung: Progyny glänzt mit blitzsauberer Bilanz und massiven Rückkäufen | Hier an der Wall Street in New York wird oft das schnelle Geld gesucht. Doch die wahren Börsenperlen findet man häufig in lukrativen Nischen, in denen ein Unternehmen zum unverzichtbaren Marktführer... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 25,860 | +0,43 % | Procept BioRobotics outlines $390M-$410M 2026 revenue, while targeting positive adjusted EBITDA in Q4 | ||
| ALIGNMENT HEALTHCARE | 6,565 | +1,00 % | Alignment Healthcare falls 9% amid weakness in Medicare Advantage stocks | ||
| UNITEDHEALTH | 314,80 | +4,58 % | UnitedHealth-Aktie -15%: Washington zieht die Daumenschrauben an - trotzdem kaufen? | Es ist bislang eine rabenschwarze Woche für die UnitedHealth-Aktie. Am Dienstag und am Mittwoch brach der Kurs der größten privaten US-Krankenversicherung in Summe um -15% ein. Was steckt hinter dem... ► Artikel lesen | |
| DRAEGERWERK | 117,20 | +1,21 % | Ihre wichtigsten Termine: Heute im Fokus: Target, Drägerwerk, Oracle, TJX, Lowe's, Bullish und Novartis | © Foto: Eibner-Pressefoto/Ardan Fuessman - Eibner-PressefotoGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,060 | -0,62 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Underweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 27 auf 26 Euro gekappt und die Aktien von "Equal Weight" auf "Underweight" abgestuft. Dem... ► Artikel lesen | |
| GENEDX | 47,130 | -4,29 % | GeneDx Taps Everett Cunningham as CEO |